Phase 4 Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are having a heart attack of a specific type (called STEMI) and are being treated with an emergency procedure to open blocked heart arteries (called primary PCI)
- People of any gender who are 18 years of age or older
Who may not be able to join:
- People whose heart attack has caused their body to go into a state of dangerous circulatory collapse (cardiogenic shock) when they arrive for treatment
- People who have a condition where the heart's electrical signals are being blocked, causing an abnormal heart rhythm (heart block)
- People who have an allergy to a medication called adenosine
- People who do not wish to give their consent to take part in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Muhammad Nauman, FCPS, National Institute of Cardiovascular Diseases
Phone: +923453549634
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary Outcome
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.